These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 20695726
1. Intermediate versus low or high prostate-specific antigen density level: comparison of cancer detection rate between 12- and 18-core prostate biopsy. Park HK, Lee KY, Kim KH, Jung H, Yoon SJ, Kim TB. Scand J Urol Nephrol; 2010 Dec; 44(6):391-8. PubMed ID: 20695726 [Abstract] [Full Text] [Related]
3. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence. Rahardjo D, Kamil ST, Pakasi LS. Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211 [Abstract] [Full Text] [Related]
5. The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml. Akdas A, Tarcan T, Türkeri L, Cevik I, Biren T, Ilker Y. Eur Urol; 1996 May; 29(2):189-92. PubMed ID: 8647145 [Abstract] [Full Text] [Related]
8. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy]. Cao XL, Gao JP, Han G, Tang J, Hong BF. Zhonghua Wai Ke Za Zhi; 2006 Mar 15; 44(6):372-5. PubMed ID: 16638344 [Abstract] [Full Text] [Related]
9. Prostate specific antigen density can help avoid unnecessary prostate biopsies at prostate specific antigen range of 4-10 ng/ml. Lodeta B, Benko G, Car S, Filipan Z, Stajcar D, Dujmović T. Acta Clin Croat; 2009 Jun 15; 48(2):153-5. PubMed ID: 19928413 [Abstract] [Full Text] [Related]
12. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group]. Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E. Hinyokika Kiyo; 1996 Oct 15; 42(10):795-804. PubMed ID: 8951478 [Abstract] [Full Text] [Related]
14. Predictive value of the international prostate symptom score for positive prostate needle biopsy in the low-intermediate prostate-specific antigen range. Kefi A, Irer B, Ozdemir I, Tuna B, Goktay Y, Yorukoğlu K, Esen A. Urol Int; 2005 Oct 15; 75(3):222-6. PubMed ID: 16215309 [Abstract] [Full Text] [Related]
17. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer. Tanaka N, Fujimoto K, Yoshikawa M, Tanaka M, Hirao Y, Kondo H, Saito I. Hinyokika Kiyo; 2007 Jul 15; 53(7):459-65. PubMed ID: 17702178 [Abstract] [Full Text] [Related]
18. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR, Evans WP, Borden JD, Castellanos RD. Cancer; 1994 Dec 01; 74(11):2991-5. PubMed ID: 7525040 [Abstract] [Full Text] [Related]
20. Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL? Yamamoto S, Ito T, Aizawa T, Noda K, Umezu K, Ohtsuru N, Hata K. Int J Urol; 2004 Jun 01; 11(6):386-91. PubMed ID: 15157207 [Abstract] [Full Text] [Related] Page: [Next] [New Search]